CRISM Therapeutics Corporation (AIM:CRTX)

London flag London · Delayed Price · Currency is GBP · Price in GBX
12.85
+2.85 (28.50%)
Apr 28, 2025, 12:12 PM GMT+1
-10.76%
Market Cap 3.27M
Revenue (ttm) -31.00K
Net Income (ttm) -7.51M
Shares Out 32.68M
EPS (ttm) -0.64
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 97,399
Average Volume 26,780
Open 8.33
Previous Close 10.00
Day's Range 8.33 - 12.85
52-Week Range 5.00 - 30.90
Beta 0.15
RSI 91.95
Earnings Date May 9, 2025

About CRISM Therapeutics

CRISM Therapeutics Corporation focuses on drug delivery technology to improve the clinical performance of cancer drugs as treatments for solid tumors. Its lead product, ChemoSeed that can be implanted directly into a tumor or the resection margin following the removal of a tumor, ensuring effective therapeutic concentrations of chemotherapy drugs directly reach the tumor tissue. Its ChemoSeed used for treatment of gliomas, a brain tumor. The company was founded in 2016 and is based in Road Town, the British Virgin Islands. [Read more]

Industry Biotechnology
Sector Healthcare
Founded 2016
Employees 4
Stock Exchange London Stock Exchange AIM
Ticker Symbol CRTX
Full Company Profile

Financial Performance

Financial Statements

News

There is no news available yet.